Abstract
We analyzed the clinical gastrointestinal (GI) characteristics of Behçet’s disease (BD) patients in Japan. We retrospectively reviewed the clinical charts of 412 patients who fulfilled the 1987 Japanese criteria for BD and were treated in two university hospitals from July 1991 to December 2007. Forty-three patients (10.4 %) had BD-related GI lesions, which were shown by imaging examinations. Median age at BD diagnosis and onset of GI episodes were 29.6 and 31.0 years, respectively. The patients suffered from abdominal pain (30/43) and GI bleeding (18/43), while they had lower frequency of eye involvement and higher incidence of arthritis and vascular involvement than BD patients without GI lesions. The lesions were prevalent in the ileum (32/43) followed by cecum (21/43) and esophagus (9/43). The patients were treated with mesalazine and sulfasalazine (41/43), corticosteroids (32/43), immunosuppressants (13/43), and infliximab for 7 patients having refractory lesions, while 10 patients had surgical operation. Two patients died due to non-GI events during the observation. The diagnosis of BD was often difficult because of lack of eye involvement. Surgery is required for some patients in spite of intensive immunosuppressive therapies. Appropriate use of anti-TNF agents may be promising for the GI involvement.
References
Mason RM, Barnes CG (1969) Behcet’s syndrome with arthritis. Ann Rheum Dis 28:95–103
International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behcet’s syndrome: a controlled study. Ann Rheum Dis 55:208–210
Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behcet disease (Behcet syndrome). Semin Arthritis Rheum 8:223–260
Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427
Bayraktar Y, Ozaslan E, Van Thiel DH (2000) Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol 30:144–154
Sfikakis PP (2002) Behcet’s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51–ii53
Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Yalcin B, Muftuoglu A (1980) Behcet’s disease as seen in Turkey. Haematologica 65:381–383
Bang D, Lee JH, Lee ES et al (2001) Epidemiologic and clinical survey of Behcet’s disease in Korea: the first multicenter study. J Korean Med Sci 16:615–618
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341:1284–1291
Nishiyama M, Nakae K, Kuriyama T, Hashimoto M, Hsu ZN (2002) A study among related pairs of Japanese patients with familial Behcet’s disease: group comparisons by interval of disease onsets. J Rheumatol 29:743–747
Mizushima Y (1988) Recent research into Behcet’s disease in Japan. Int J Tissue React 10:59–65
Suzuki Kurokawa M, Suzuki N (2004) Behcet’s disease. Clin Exp Med 4:10–20
Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behcet disease: evolution of clinical manifestations. Medicine (Baltimore) 90:125–132
Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T (1981) Intestinal involvement in Behcet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 24:103–106
Lee RG (1986) The colitis of Behcet’s syndrome. Am J Surg Pathol 10:888–893
Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY (2000) Long-term clinical course and prognostic factors in intestinal Behcet’s disease. Dis Colon Rectum 43:692–700
Iwama T, Utzunomiya J (1977) Anal complication in Behcet’s syndrome. Jpn J Surg 7:114–117
Yi SW, Cheon JH, Kim JH, Lee SK, Kim TI, Lee YC, Kim WH (2009) The prevalence and clinical characteristics of esophageal involvement in patients with Behcet’s disease: a single center experience in Korea. J Korean Med Sci 24:52–56
Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 67:1656–1662
Tohme A, Aoun N, El-Rassi B, Ghayad E (2003) Vascular manifestations of Behcet’s disease. Eighteen cases among 140 patients. Joint Bone Spine 70:384–389
Acknowledgments
This work was supported by grants from the Behçet’s Disease Research Committee, Research on Specific Disease of the Health Science Research Grants from the Ministry of Health, Labour, and Welfare (Y. Ishigatsubo). The source of funding played no role in the writing of the report or in the decision to publish the results; and by 2011–2013 grant-in-aid for scientific research (project No. 23591443) from the Ministry of Education, Culture, Sports, and Technology of Japan (to M. Takeno).
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ideguchi, H., Suda, A., Takeno, M. et al. Gastrointestinal manifestations of Behçet’s disease in Japan: a study of 43 patients. Rheumatol Int 34, 851–856 (2014). https://doi.org/10.1007/s00296-013-2838-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2838-5